# FMCG Processing - Other — company-by-company sector analysis

> FMCG Processing - Other: Orkla India Ltd owns the largest revenue base; Mukka Proteins Ltd has the fastest current growth.

Sector Alpha — machine-written from the numbers. Data as of 2026-08-20. Not investment advice.

## Bottom line

FMCG Processing - Other has underperformed NIFTY 500 by 16.5% over 52 weeks and 4.5% over 13 weeks. 1 of 1 covered companies beat NIFTY on Mansfield relative strength, while 1 of 1 beat the sector itself. Orkla India Ltd leads with revenue of ₹2,571 crore, based on 2 of 2 comparable companies through Jun 2026.

## Sector relative strength

FMCG Processing - Other has underperformed NIFTY 500 by 16.5% over the last 52 weeks. Over 13 weeks the gap is a shortfall of 4.5%. 1 of 1 covered company currently beats NIFTY on Mansfield relative strength, so leadership inside the sector is broad. Mukka Proteins Ltd is the strongest against the sector itself at +12%.

13-week sector return versus NIFTY 500: -4.5%
52-week sector return versus NIFTY 500: -17%
Stocks leading NIFTY: 1/1
Stocks leading sector: 1/1

Central tension: The central tension: the companies with the most scale are not necessarily the companies creating the most change.

Companies: 2
Combined market value: ₹8.3K Cr

## 4-Factor Sector Score

An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.

1. Mukka Proteins Ltd (MUKKA): 66/100 — Favorable setup; evidence 77%
   - Growth & earnings 27.2/35 | Capital efficiency 8.6/25 | Valuation 10.0/20 | Relative strength 20.0/20
   - Price stage: TURNING — Ahead of the benchmark for one to four weeks, after a stretch of being behind.
   - Led NIFTY 500 by 5%+ over the prior 13 weeks in 4 of the last 12 weeks
   - Exact sum: 27.2 + 8.6 + 10 + 20 = 65.8
   - Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2. Orkla India Ltd (ORKLAINDIA): 43/100 — Mixed-negative evidence; evidence 70%
   - Growth & earnings 12.2/35 | Capital efficiency 13.1/25 | Valuation 7.8/20 | Relative strength 10.0/20
   - Price stage: ASLEEP — Neither ahead of the benchmark nor yet turning up against it.
   - Led NIFTY 500 by 5%+ over the prior 13 weeks in 1 of the last 12 weeks
   - Exact sum: 12.2 + 13.1 + 7.8 + 10 = 43.1
   - Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

## Market action

Mukka Proteins Ltd has the strongest one-year price move in FMCG Processing - Other at -2.5%. It also leads on Mansfield relative strength against NIFTY at +7.7%. 1 of 1 covered company is above zero on that measure. Every line covers 313 weekly closes through 2026-08-14.

### Strongest one-year price performers
1. Mukka Proteins Ltd (MUKKA): -2.5%

### Strongest relative strength versus NIFTY 500
1. Mukka Proteins Ltd (MUKKA): 7.7%

## FMCG Processing - Other — the story behind the numbers

This is the written read behind the FMCG Processing - Other figures above — what is actually happening in the sector, in words, with the evidence each claim rests on. It is dated 17 Apr 2026, so the words are older than the numbers. 2 themes are live here.

The FMCG Processing - Other sector presents a mixed near-term picture but a compelling long-term thesis. While severe commodity deflation has temporarily suppressed value realization and caused a miss in volume guidance, the underlying operational leverage is highly resilient, as evidenced by the 17.7% EBITDA growth.

The FMCG Processing - Other sector, represented solely by Orkla India Ltd (ORKLAINDIA) in this week's analysis, is navigating a complex but ultimately IMPROVING demand environment. For Q3 FY26, ORKLAINDIA reported a modest revenue growth of 3.4% year-on-year, reaching INR 636 crores. However, the company missed its volume growth guidance.

How old this read is: STALE — this read comes from our FMCG Processing - Other sector brief dated 17 Apr 2026, about 4 months ago. The page says so rather than dressing it up, and a fresh sector dive replaces it the day it runs.

### Live themes, worst first
- MEDIUM | Deflation in spices, specifically a 50% drop in chili prices, is impacting value realization. | Passing on price benefits to remain competitive while focusing on volume growth. | quoted: "This unprecedented price movement of over 30% was led by chili, which reduced by 50%. This has impacted our value realization." | named for ORKLAINDIA
- LOW | The Red Sea crisis impacted US distribution and led to stock build-up. | Working to cut stock levels to normalized levels by Q1 FY27. | quoted: "there's been a little bit -- and also the Red Sea crisis was there last year. So there was a lot of stock build-up." | named for ORKLAINDIA

Sources: our FMCG Processing - Other sector brief, 17 Apr 2026 · company earnings-call transcripts.

## Revenue Scale & Growth Durability

What the numbers say: Orkla India Ltd is the scale leader at ₹2,571 crore, 45.3% ahead of Mukka Proteins Ltd. Mukka Proteins Ltd's growth is 76.1% from a ₹1,770 crore base, with 15 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.

Investor read: Orkla India Ltd is the scale benchmark; Mukka Proteins Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.

This conclusion weakens if: Orkla India Ltd's growth falls below Mukka Proteins Ltd's for two consecutive comparable reports while operating margin also compresses.

Evidence: Orkla India Ltd · ₹2,571 crore | 45.3% versus #2 · Mukka Proteins Ltd | 5/5 recent comparable periods | 2/2 companies · 24 observations

Definition: Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.

### Revenue — largest
1. Orkla India Ltd (ORKLAINDIA): ₹2.6K Cr
2. Mukka Proteins Ltd (MUKKA): ₹1.8K Cr

### Revenue growth — fastest growers
1. Mukka Proteins Ltd (MUKKA): 76%
2. Orkla India Ltd (ORKLAINDIA): 5.9%

### 20-quarter Revenue history
- ORKLAINDIA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 — | Sep 2023 — | Dec 2023 — | Mar 2024 — | Jun 2024 ₹564 Cr | Sep 2024 ₹620 Cr | Dec 2024 ₹615 Cr | Mar 2025 ₹596 Cr | Jun 2025 ₹597 Cr | Sep 2025 ₹650 Cr | Dec 2025 ₹636 Cr | Mar 2026 ₹626 Cr | Jun 2026 ₹659 Cr
- MUKKA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 ₹397 Cr | Mar 2023 ₹421 Cr | Jun 2023 ₹274 Cr | Sep 2023 ₹332 Cr | Dec 2023 ₹517 Cr | Mar 2024 ₹257 Cr | Jun 2024 ₹172 Cr | Sep 2024 ₹149 Cr | Dec 2024 ₹303 Cr | Mar 2025 ₹382 Cr | Jun 2025 ₹171 Cr | Sep 2025 ₹245 Cr | Dec 2025 ₹654 Cr | Mar 2026 ₹381 Cr | Jun 2026 ₹490 Cr

### 20-quarter Revenue growth history
- ORKLAINDIA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 — | Sep 2023 — | Dec 2023 — | Mar 2024 — | Jun 2024 — | Sep 2024 — | Dec 2024 — | Mar 2025 — | Jun 2025 5.9% | Sep 2025 4.8% | Dec 2025 3.4% | Mar 2026 5.0% | Jun 2026 10%
- MUKKA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 — | Sep 2023 — | Dec 2023 30% | Mar 2024 -39% | Jun 2024 -37% | Sep 2024 -55% | Dec 2024 -41% | Mar 2025 49% | Jun 2025 -0.6% | Sep 2025 64% | Dec 2025 116% | Mar 2026 -0.3% | Jun 2026 187%

## Operating Economics & Margin Trend

What the numbers say: Orkla India Ltd leads opm at 17%; Mukka Proteins Ltd leads margin change at +2 percentage points.

Investor read: Orkla India Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current margin change signal.

Evidence: Orkla India Ltd · 17% | 70% versus #2 · Mukka Proteins Ltd | 2/5 recent comparable periods | 2/2 companies · 24 observations

Definition: Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.

### OPM — highest
1. Orkla India Ltd (ORKLAINDIA): 17%
2. Mukka Proteins Ltd (MUKKA): 10%

### Margin change — fastest expanders
1. Mukka Proteins Ltd (MUKKA): +2.0 pp
2. Orkla India Ltd (ORKLAINDIA): −2.0 pp

### 20-quarter OPM history
- ORKLAINDIA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 — | Sep 2023 — | Dec 2023 — | Mar 2024 — | Jun 2024 15% | Sep 2024 18% | Dec 2024 14% | Mar 2025 16% | Jun 2025 19% | Sep 2025 16% | Dec 2025 16% | Mar 2026 16% | Jun 2026 17%
- MUKKA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 9.0% | Mar 2023 10% | Jun 2023 5.0% | Sep 2023 11% | Dec 2023 3.6% | Mar 2024 13% | Jun 2024 8.0% | Sep 2024 6.0% | Dec 2024 14% | Mar 2025 8.0% | Jun 2025 8.0% | Sep 2025 8.0% | Dec 2025 7.0% | Mar 2026 9.0% | Jun 2026 10%

### 20-quarter Margin change history
- ORKLAINDIA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 — | Sep 2023 — | Dec 2023 — | Mar 2024 — | Jun 2024 — | Sep 2024 — | Dec 2024 — | Mar 2025 — | Jun 2025 +3.6 pp | Sep 2025 −2.0 pp | Dec 2025 +2.0 pp | Mar 2026 0.0 pp | Jun 2026 −2.0 pp
- MUKKA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 — | Sep 2023 — | Dec 2023 −5.4 pp | Mar 2024 +3.0 pp | Jun 2024 +3.0 pp | Sep 2024 −5.0 pp | Dec 2024 +10.4 pp | Mar 2025 −5.0 pp | Jun 2025 0.0 pp | Sep 2025 +2.0 pp | Dec 2025 −7.0 pp | Mar 2026 +1.0 pp | Jun 2026 +2.0 pp

## Profit Scale & Acceleration

What the numbers say: Orkla India Ltd leads with ₹295 crore of TTM profit, 298.6% above Mukka Proteins Ltd. Mukka Proteins Ltd shows 68.2% growth from a ₹74 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.

Investor read: Orkla India Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.

Evidence: Orkla India Ltd · ₹295 crore | 298.6% versus #2 · Mukka Proteins Ltd | 3/5 recent comparable periods | 2/2 companies · 24 observations

Definition: Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.

### Net profit — largest
1. Orkla India Ltd (ORKLAINDIA): ₹295 Cr
2. Mukka Proteins Ltd (MUKKA): ₹74 Cr

### Profit growth — fastest growers
1. Mukka Proteins Ltd (MUKKA): 68%
2. Orkla India Ltd (ORKLAINDIA): 12%

### 20-quarter Net profit history
- ORKLAINDIA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 — | Sep 2023 — | Dec 2023 — | Mar 2024 — | Jun 2024 ₹72 Cr | Sep 2024 ₹83 Cr | Dec 2024 ₹66 Cr | Mar 2025 ₹35 Cr | Jun 2025 ₹79 Cr | Sep 2025 ₹77 Cr | Dec 2025 ₹57 Cr | Mar 2026 ₹73 Cr | Jun 2026 ₹88 Cr
- MUKKA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 ₹27 Cr | Mar 2023 ₹22 Cr | Jun 2023 ₹4 Cr | Sep 2023 ₹29 Cr | Dec 2023 ₹12 Cr | Mar 2024 ₹29 Cr | Jun 2024 ₹5 Cr | Sep 2024 ₹1 Cr | Dec 2024 ₹27 Cr | Mar 2025 ₹14 Cr | Jun 2025 ₹2 Cr | Sep 2025 ₹7 Cr | Dec 2025 ₹27 Cr | Mar 2026 ₹21 Cr | Jun 2026 ₹19 Cr

### 20-quarter Profit growth history
- ORKLAINDIA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 — | Sep 2023 — | Dec 2023 — | Mar 2024 — | Jun 2024 — | Sep 2024 — | Dec 2024 — | Mar 2025 — | Jun 2025 9.7% | Sep 2025 -7.2% | Dec 2025 -14% | Mar 2026 109% | Jun 2026 11%
- MUKKA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 — | Sep 2023 — | Dec 2023 -56% | Mar 2024 32% | Jun 2024 25% | Sep 2024 -97% | Dec 2024 125% | Mar 2025 -52% | Jun 2025 -60% | Sep 2025 600% | Dec 2025 0.0% | Mar 2026 50% | Jun 2026 850%

## Return On Capital Employed

What the numbers say: Orkla India Ltd leads ROCE at 14.9%, 3.3 percentage points above Mukka Proteins Ltd. Orkla India Ltd has the strongest latest improvement at -0.3 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.

Investor read: Orkla India Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current roce change signal.

Evidence: Orkla India Ltd · 14.9% | 28.4% versus #2 · Mukka Proteins Ltd | 0/1 recent comparable periods | 2/2 companies · 22 observations

Definition: ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.

### ROCE — highest
1. Orkla India Ltd (ORKLAINDIA): 15%
2. Mukka Proteins Ltd (MUKKA): 12%

### ROCE change — fastest improvers
1. Orkla India Ltd (ORKLAINDIA): −0.3 pp
2. Mukka Proteins Ltd (MUKKA): −0.6 pp

### 20-quarter ROCE history
- ORKLAINDIA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 — | Sep 2023 — | Dec 2023 — | Mar 2024 — | Jun 2024 — | Sep 2024 — | Dec 2024 — | Mar 2025 13% | Jun 2025 13% | Sep 2025 12% | Dec 2025 13% | Mar 2026 13% | Jun 2026 —
- MUKKA: Mar 2021 — | Jun 2021 7.1% | Sep 2021 14% | Dec 2021 24% | Mar 2022 36% | Dec 2022 45% | Mar 2023 57% | Jun 2023 — | Sep 2023 58% | Dec 2023 67% | Mar 2024 23% | Jun 2024 38% | Sep 2024 15% | Dec 2024 33% | Mar 2025 18% | Jun 2025 22% | Sep 2025 19% | Dec 2025 25% | Mar 2026 17% | Jun 2026 —

### 20-quarter ROCE change history
- ORKLAINDIA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 — | Sep 2023 — | Dec 2023 — | Mar 2024 — | Jun 2024 — | Sep 2024 — | Dec 2024 — | Mar 2025 — | Jun 2025 — | Sep 2025 — | Dec 2025 — | Mar 2026 −0.3 pp | Jun 2026 —
- MUKKA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 +38.2 pp | Mar 2023 +42.7 pp | Jun 2023 — | Sep 2023 +21.1 pp | Dec 2023 +21.2 pp | Mar 2024 −34.1 pp | Jun 2024 — | Sep 2024 −42.4 pp | Dec 2024 −34.0 pp | Mar 2025 −5.1 pp | Jun 2025 −15.9 pp | Sep 2025 +4.3 pp | Dec 2025 −7.1 pp | Mar 2026 −0.6 pp | Jun 2026 —

## Valuation Against Growth & Quality

What the numbers say: Orkla India Ltd has the lowest comparable PEG at 2.19×. Only 1 of 2 companies have earnings and growth steady enough for the ratio to mean anything, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.

Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.

This conclusion weakens if: The next two comparable reports reverse the current p/e signal.

Evidence: Orkla India Ltd · 2.19× | Not enough peers | 0/3 recent comparable periods | 1/2 companies · 0 observations

Definition: PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is recomputed consistently as the trailing P/E divided by that growth rate — reported earnings, never an expected-earnings multiple. On Indian companies it is shown only where the two data feeds agreed. Where any of that fails the ratio is left out rather than printed: a P/E divided by a loss, or by growth measured off a tiny base, is a number that looks precise and means nothing.

### PEG — lowest PEG
1. Orkla India Ltd (ORKLAINDIA): 2.2

### P/E — lowest P/E
1. Mukka Proteins Ltd (MUKKA): 11.5
2. Orkla India Ltd (ORKLAINDIA): 24.6

### 20-quarter PEG history

### 20-quarter P/E history
- ORKLAINDIA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 — | Sep 2023 — | Dec 2023 — | Mar 2024 — | Jun 2024 — | Sep 2024 — | Dec 2024 — | Mar 2025 — | Jun 2025 — | Sep 2025 — | Dec 2025 3.4 | Mar 2026 3.1 | Jun 2026 3.3
- MUKKA: Mar 2021 — | Jun 2021 — | Sep 2021 — | Dec 2021 — | Mar 2022 — | Dec 2022 — | Mar 2023 — | Jun 2023 — | Sep 2023 — | Dec 2023 — | Mar 2024 12.5 | Jun 2024 12.5 | Sep 2024 14.9 | Dec 2024 24.4 | Mar 2025 16.4 | Jun 2025 19.5 | Sep 2025 18.2 | Dec 2025 15.2 | Mar 2026 13.3 | Jun 2026 14.0


## What can make this comparison misleading?
- A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
- A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
- The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
- An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
- 1 company draws at least one figure from a second data feed with too little overlapping history to cross-check against the primary source; it is marked unverified wherever that figure appears.
- Thin comparisons: Valuation have fewer than three usable current readings.

## Every company
- Orkla India Ltd (ORKLAINDIA) — market value ₹7.5K Cr; latest fundamentals Jun 2026
- Mukka Proteins Ltd (MUKKA) — market value ₹795 Cr; latest fundamentals Jun 2026; includes UNVERIFIED second-feed figures

## Source standing of each company

Cross-checked: 1. Unverified: 1. Withheld: 0. Graded companies: 2.

1 of 2 companies draws at least one figure from a second data feed that could not be cross-checked against the primary source, because the two do not share enough reported history to compare. Those figures are marked unverified wherever they appear.

- UNVERIFIED | MUKKA | Mukka Proteins Ltd | too little overlapping reported history to cross-check the second feed

## Methodology and freshness

Fundamentals through Jun 2026; prices through 2026-08-14.
Up to 20 quarters per company. Reported history is normalized to Indian rupees crore. Missing values are not interpolated. Derived metrics are calculated only when their inputs are comparable.

## Frequently asked questions

### Is the FMCG Processing - Other sector outperforming NIFTY 500?

FMCG Processing - Other has underperformed NIFTY 500 by 16.5% over 52 weeks and 4.5% over 13 weeks. 1 of 1 covered companies beat NIFTY on Mansfield relative strength, while 1 of 1 beat the sector itself.

### Which FMCG Processing - Other company is largest by revenue?

Orkla India Ltd leads with revenue of ₹2,571 crore, based on 2 of 2 comparable companies through Jun 2026.

### Which FMCG Processing - Other company is growing fastest?

Mukka Proteins Ltd has the fastest current revenue growth at 76.1%, across 2 of 2 comparable companies.

### Which FMCG Processing - Other company has the strongest 4-Factor Sector Score?

Mukka Proteins Ltd ranks first at 65.8/100 with 77% evidence confidence. The score prioritizes research; it is not a buy recommendation.

### Which FMCG Processing - Other company has the lowest comparable PEG?

Orkla India Ltd has the lowest comparable PEG at 2.19, among 1 of 2 companies whose earnings and growth are steady enough for the ratio to mean anything.

### How much history does this FMCG Processing - Other comparison include?

The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.

### How is the 4-Factor Sector Score calculated?

The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.

### Is there a Nifty FMCG Processing - Other index?

NSE India maintains Nifty indices for several broad sector categories — Nifty Bank, Nifty IT, Nifty Pharma and others — but not for every sub-sector grouping on this site. Whether or not an official Nifty index covers FMCG Processing - Other, this page builds its own equal-weight basket of 2 listed FMCG Processing - Other companies — one company, one vote, regardless of market value — so no single large company dominates the reading. Figures are as of Jun 2026.

### Which are the best FMCG Processing - Other stocks in India?

Ranked by this page's four-factor score, Mukka Proteins Ltd places first among 2 listed FMCG Processing - Other companies, followed by Orkla India Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Jun 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.

### How many FMCG Processing - Other stocks are listed in India?

This comparison covers 2 listed FMCG Processing - Other companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Jun 2026.

### Which FMCG Processing - Other company is the biggest?

Orkla India Ltd is the largest, with trailing-twelve-month revenue of ₹2,571 crore, ahead of Mukka Proteins Ltd at ₹1,770 crore. That covers 2 of 2 companies with comparable reporting through Jun 2026.

### Which FMCG Processing - Other company has the best profit margins?

Orkla India Ltd has the highest operating margin at 17%, from 2 of 2 comparable companies. Mukka Proteins Ltd shows the biggest recent improvement, at +2 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.

### Which FMCG Processing - Other company makes the most profit?

Orkla India Ltd earns the most, at ₹295 crore of trailing-twelve-month net profit, from 2 of 2 comparable companies. Mukka Proteins Ltd has the fastest profit growth at 68.2%, though growth off a small or recovering profit base overstates how much has actually changed.

### Which FMCG Processing - Other company earns the highest return on capital?

Orkla India Ltd leads on return on capital employed at 14.9%, across 2 of 2 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.

### Which FMCG Processing - Other stock is the cheapest?

On PEG — where a LOWER number is cheaper — Orkla India Ltd screens cheapest at 2.19×. Only 1 of 2 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.

### Is the FMCG Processing - Other sector beating the market?

FMCG Processing - Other has underperformed NIFTY 500 by 16.5% over the last 52 weeks and 4.5% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 1 of 1 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.

### Which FMCG Processing - Other stock has the strongest price momentum?

Mukka Proteins Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.

### Which FMCG Processing - Other company scores highest for research priority?

Mukka Proteins Ltd scores 65.8 out of 100 with 77% evidence confidence, from 27.2 points on growth and earnings, 8.6 on capital efficiency, 10 on valuation and 20 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.

### How many FMCG Processing - Other companies does this comparison cover, and over what period?

It compares 2 listed companies over up to 20 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.

### What is the total market cap of the FMCG Processing - Other sector?

The 2 FMCG Processing - Other companies on this page carry ₹8,326 crore of combined market value. Orkla India Ltd is the largest at ₹7,531 crore, about 90% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-08-20.

### How is the FMCG Processing - Other sector performing?

1 of the 1 covered FMCG Processing - Other companies are beating NIFTY 500 on Mansfield relative strength. The sector itself is 16.5% behind NIFTY 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-08-20.

### Why are some values on this page blank?

A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.

### Is this investment advice?

No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.